• Citer

NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome

par Eyre, Toby Andrew;Clifford, Ruth;Bloor, Adrian;Boyle, Lucy;Roberts, Corran;Cabes, Maite;Collins, Graham Peter;Devereux, Stephen;Follows, George;Fox, Christopher C.P.;John, Gribben G.G.;Hillmen, Peter;Hatton, Chris Simon Ross C.S.;Littlewood, Tim James;McCarthy, Helen;Murray, Jim;Pettitt, Andrew A.R.;Soilleux, Elizabeth;Stamatopoulos, Basile ;Love, Sharon S.B.;Wotherspoon, Andrew;Schuh, Anna
Référence British journal of haematology, 175, 1, page (43-54)
Publication Publié, 2016-10

Article révisé par les pairs

• Détails
• Contenu

Titre:	NCRI phase II study of CHOP in combination with ofatumumab in induction and maintenance in newly diagnosed Richter syndrome
Auteur:	Eyre, Toby Andrew; Clifford, Ruth; Bloor, Adrian; Boyle, Lucy; Roberts, Corran; Cabes, Maite; Collins, Graham Peter; Devereux, Stephen; Follows, George; Fox, Christopher C.P.; John, Gribben G.G.; Hillmen, Peter; Hatton, Chris Simon Ross C.S.; Littlewood, Tim James; McCarthy, Helen; Murray, Jim; Pettitt, Andrew A.R.; Soilleux, Elizabeth; Stamatopoulos, Basile; Love, Sharon S.B.; Wotherspoon, Andrew; Schuh, Anna
Informations sur la publication:	British journal of haematology, 175, 1, page (43-54)
Statut de publication:	Publié, 2016-10
Sujet CREF:	Hématologie
Mots-clés:	CHOP
	Chronic lymphocytic leukaemia
	Ofatumumab
	Richter syndrome
	TP53
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0007-1048
	info:doi/10.1111/bjh.14177
	info:scp/84988457283
	info:pmid/27378086